Publication Name	World Journal of Gastroenterology
Manuscript ID	12828
Country	South Korea

Received	2014-07-27 14:50
Peer-Review Started	2014-07-27 16:15
To Make the First Decision	2014-08-15 12:19
Return for Revision	2014-08-23 16:13
Revised	2014-09-12 18:51
Second Decision	2014-11-11 10:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-11-11 10:31
Articles in Press	2014-11-11 11:07
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-12-22 03:15
Typeset the Manuscript	2015-01-31 10:36
Publish the Manuscript Online	2015-02-11 17:56

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Retreatment with peginterferon and ribavirin in chronic hepatitis C
Manuscript Source	Unsolicited Manuscript
All Author List	Yong Min Jo, Sung Wook Lee, Sang Young Han, Yang Hyun Baek, Soo Young Kim, Woo Jae Kim, Ji Hye Ahn and Ji Young Lee
Funding Agency and Grant Number
Corresponding Author	Sung Wook Lee, MD, PhD, Department of Internal Medicine, Dong-A University School of Medicine, 3 Ga 1, Dongdaesin-dong, Seo-gu, Busan 602-715, South Korea. sunglee@dau.ac.kr
Key Words	Chronic hepatitis C; Direct-acting antiviral agents; Peginterferon; Ribavirin; Retreatment
Core Tip	Chronic hepatitis C-infected patients who experience relapse shortly after completing treatment with peginterferon and ribavirin have a reasonable chance of achieving a sustained virologic response when retreated with these drugs alone. Thus, it would be very reasonable to proceed with peginterferon and ribavirin retreatment alone, particularly in patients with factors associated with high rates of sustained virologic response, such as a low viral load at relapse (< 400000 IU/mL) and an early virologic response at week 12 of retreatment.
Publish Date	2015-02-11 17:56
Citation	Jo YM, Lee SW, Han SY, Baek YH, Kim SY, Kim WJ, Ahn JH, Lee JY. Retreatment with peginterferon and ribavirin in chronic hepatitis C. World J Gastroenterol 2015; 21(6): 1994-1999
URL	http://www.wjgnet.com/1007-9327/full/v21/i6/1994.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i6.1994

Full Article (PDF)	WJG-21-1994.pdf
Full Article (Word)	WJG-21-1994.doc
Manuscript File	12828-Review.docx
Answering Reviewers	12828-Answering reviewers.pdf
Copyright License Agreement	12828-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	12828-Language certificate.pdf
Peer-review Report	12828-Peer review(s).pdf
Scientific Misconduct Check	12828-CrossCheck.jpg
Scientific Editor Work List	12828-Scientific editor work list.pdf